
Join to View Full Profile
2510 30th AveLong Island City, NY 11102
Phone+1 718-267-4245
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Naris Nilubol, MD is a general surgeon in Long Island City, New York. He is currently licensed to practice medicine in Illinois.
Education & Training
- Icahn School of Medicine at Mount SinaiResidency, Surgery, 2000 - 2005
- Chulalongkorn University Faculty of MedicineClass of 1997
Certifications & Licensure
- IL State Medical License 2005 - 2026
- American Board of Surgery Surgery
Publications & Presentations
PubMed
- Elevated levels of circulating microbial-associated uremic toxins are associated with metastatic duodenopancreatic neuroendocrine tumors in patients with Multiple Endo...Riccardo Ballarò, Amanda R Wasylishen, Carolina R C Pieterman, Courtney Olsen, Ehsan Irajizad
Cancer Letters. 2025-04-01 - 3 citationsProgress in surgical approaches and outcomes of patients with pheochromocytoma and paraganglioma.Lindsay R Friedman, Bhavishya Ramamoorthy, Naris Nilubol
Best Practice & Research. Clinical Endocrinology & Metabolism. 2025-01-01 - 5 citationsInternational consensus statement on the diagnosis and management of phaeochromocytoma and paraganglioma in children and adolescents.Ruth T Casey, Emile Hendriks, Cheri Deal, Steven G Waguespack, Verena Wiegering
Nature Reviews. Endocrinology. 2024-12-01
Authored Content
- Tumor Size and Presence of Metastatic Disease at Diagnosis Are Associated withJuly 2018
- Probability of Positive Genetic Testing Results in Patients with Family HistoryFebruary 2018
Grant Support
- Therapeutic targets and novel anticancer agents for endocrine cancersDIVISION OF BASIC SCIENCES - NCIPresent
- Therapeutic targets and novel anticancer agents for endocrine cancersDIVISION OF BASIC SCIENCES - NCIPresent
- Therapeutic targets and novel anticancer agents for endocrine cancersDIVISION OF BASIC SCIENCES - NCIPresent